NF-κB inhibition prevents acute shear stress-induced inflammation in the saphenous vein graft endothelium.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 09 2020
Historique:
received: 16 12 2019
accepted: 14 08 2020
entrez: 16 9 2020
pubmed: 17 9 2020
medline: 16 12 2020
Statut: epublish

Résumé

The long saphenous vein (LSV) is commonly used as a conduit in coronary artery bypass grafting. However, long term patency remains limited by the development of vascular inflammation, intimal hyperplasia and accelerated atherosclerosis. The impact of acute exposure of venous endothelial cells (ECs) to acute arterial wall shear stress (WSS) in the arterial circulation, and the subsequent activation of inflammatory pathways, remain poorly defined. Here, we tested the hypothesis that acute exposure of venous ECs to high shear stress is associated with inflammatory responses that are regulated by NF-κB both in-vitro and ex-vivo. Analysis of the LSV endothelium revealed that activation of NF-κB occurred within 30 min after exposure to arterial rates of shear stress. Activation of NF-κB was associated with increased levels of CCL2 production and enhanced binding of monocytes in LSVECs exposed to 6 h acute arterial WSS. Consistent with this, ex vivo exposure of LSVs to acute arterial WSS promoted monocyte interactions with the vessel lumen. Inhibition of the NF-κB pathway prevented acute arterial WSS-induced CCL2 production and reduced monocyte adhesion, both in vitro and in human LSV ex vivo, demonstrating that this pathway is necessary for the induction of the acute arterial WSS-induced pro-inflammatory response. We have identified NF-κB as a critical regulator of acute endothelial inflammation in saphenous vein in response to acute arterial WSS. Localised endothelial-specific inhibition of the NF-κB pathway may be beneficial to prevent vein graft inflammation and consequent failure.

Identifiants

pubmed: 32934266
doi: 10.1038/s41598-020-71781-6
pii: 10.1038/s41598-020-71781-6
pmc: PMC7492228
doi:

Substances chimiques

BAY 11-7085 0
NF-kappa B 0
Nitriles 0
Sulfones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15133

Subventions

Organisme : Department of Health
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/17/1/32804
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1992027/7163
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/19/10/34506
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/33/31394
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/18/1/33234
Pays : United Kingdom

Références

Mozaffarian, D. et al. Heart disease and stroke statistics—2016 update a report from the American Heart Association. Circulation 131(4), e29-322 (2015).
Alderman, E. L. et al. Results of coronary-artery surgery in patients with poor left-ventricular function (CASS). Circulation 68, 785–795 (1983).
doi: 10.1161/01.CIR.68.4.785
Alderman, E. et al. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease—The bypass angioplasty revascularization investigation (BARI). Circulation 96, 1761–1769 (1997).
doi: 10.1161/01.CIR.96.6.1761
Eagle, K. A. et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004(110), e340-437 (2004).
Serruys, P. W. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 360, 961–972 (2009).
doi: 10.1056/NEJMoa0804626
Mohr, F. W. et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381, 629–638 (2013).
doi: 10.1016/S0140-6736(13)60141-5
Motwani, J. G. & Topol, E. J. Aortocoronary saphenous vein graft disease—Pathogenesis, predisposition, and prevention. Circulation 97, 916–931 (1998).
doi: 10.1161/01.CIR.97.9.916
Sabik, J. F. Understanding saphenous vein graft patency. Circulation 124, 273–275 (2011).
doi: 10.1161/CIRCULATIONAHA.111.039842
Newby, A. C. & Zaltsman, A. B. Molecular mechanisms in intimal hyperplasia. J. Pathol. 190, 300–309 (2000).
doi: 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I
Wan, S., George, S. J., Berry, C. & Baker, A. H. Vein graft failure: Current clinical practice and potential for gene therapeutics. Gene Ther. 19, 630–636 (2012).
doi: 10.1038/gt.2012.29
Lehoux, S., Castier, Y. & Tedgui, A. Molecular mechanisms of the vascular responses to haemodynamic forces. J. Intern. Med. 259, 381–392 (2006).
doi: 10.1111/j.1365-2796.2006.01624.x
Golledge, J., Gosling, M., Turner, R. J., Standfield, N. J. & Powell, J. T. Arterial flow induces changes in saphenous vein endothelium proteins transduced by cation channels. Eur. J. Vasc. Endovasc. Surg. 19, 545–550 (2000).
doi: 10.1053/ejvs.1999.1059
Gusic, R. J., Myung, R., Petko, M., Gaynor, J. W. & Gooch, K. J. Shear stress and pressure modulate saphenous vein remodeling ex vivo. J. Biomech. 38(9), 1760–1769 (2005).
doi: 10.1016/j.jbiomech.2004.10.030
Hay, D. C. et al. Activation of NF-kappa B nuclear transcription factor by flow in human endothelial cells. Biochimica Et Biophysica Acta Mol. Cell Res. 1642, 33–44 (2003).
doi: 10.1016/S0167-4889(03)00084-3
Casarin, S., Bercelli, S. A. & Garbey, M. Linking gene dynamics to vascular hyperplasia—Toward a predictive model of vein graft adaptation. PLoS ONE 12(1), e1087606 (2017).
Qin, Q. et al. Lisa: Inferring transcriptional regulators through integrative modeling of public chromatin accessibility and ChIP-seq data. Genome Biol. 21, 32 (2020).
doi: 10.1186/s13059-020-1934-6
Souza, D. S. R. et al. Improved patency in vein grafts harvested with surrounding tissue: Results of a randomized study using three harvesting techniques. Ann. Thorac. Surg. 73, 1189–1195 (2002).
doi: 10.1016/S0003-4975(02)03425-2
Angelini, G. D., Bryan, A. J., Williams, H. M. J., Morgan, R. & Newby, A. C. Distension promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J. Thorac. Cardiovasc. Surg. 99, 433–439 (1990).
doi: 10.1016/S0022-5223(19)36973-9
Ward, A. O., Caputo, M., Angelini, G. D., George, S. J. & Zakkar, M. Activation and inflammation of the venous endothelium in vein graft disease. Atherosclerosis. 265, 266–274 (2017).
doi: 10.1016/j.atherosclerosis.2017.08.023
Ruiter, M. S. & Pesce, M. Mechanotransduction in coronary vein graft disease. Front. Cardiovasc. Med. 5, 20 (2018).
doi: 10.3389/fcvm.2018.00020
Hwang, H. Y., Koo, B. K., Yeom, S. Y., Kim, T. K. & Kim, K. B. Endothelial shear stress of the saphenous vein composite graft based on the internal thoracic artery. Ann. Thorac. Surg. 105(2), 564–571 (2018).
doi: 10.1016/j.athoracsur.2017.08.025
Zakkar, M. et al. Dexamethasone arterializes venous endothelial cells by inducing mitogen-activated protein kinase phosphatase-1 a novel antiinflammatory treatment for vein grafts?. Circulation 123, 524-U141 (2011).
doi: 10.1161/CIRCULATIONAHA.110.979542
Surapisitchat, J. et al. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. USA. 98, 6476–6481 (2001).
doi: 10.1073/pnas.101134098
Zakkar, M. et al. Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ. Res. 103, 726–732 (2008).
doi: 10.1161/CIRCRESAHA.108.183913
Zakkar, M., Angelini, G. & Emanueli, C. Regulation of vascular endothelium inflammatory signalling by shear stress. Curr. Vasc. Pharmacol. 2015.
Lan, Q. X., Mercurius, K. O. & Davies, P. F. Stimulation of transcription factors NF-kappa-B and AP-1 in endothelial-cells subjected to shear-stress. Biochem. Biophys. Res. Commun. 201, 950–956 (1994).
doi: 10.1006/bbrc.1994.1794
Bhullar, I. S. et al. Fluid shear stress activation of I kappa B kinase is integrin-dependent. J. Biol. Chem. 273, 30544–30549 (1998).
doi: 10.1074/jbc.273.46.30544
Schepers, A. et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 26, 2063–2069 (2006).
doi: 10.1161/01.ATV.0000235694.69719.e2
Fu, C. H. et al. Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations. Arterioscler. Thromb. Vasc. Biol. 32, 2418–2428 (2012).
doi: 10.1161/ATVBAHA.112.255786
Shintani, T. et al. Intraoperative transfection of vein grafts with the NF kappa B decoy in a canine aortocoronary bypass model: A strategy to attenuate intimal hyperplasia. Ann. Thorac. Surg. 74, 1132–1137 (2002).
doi: 10.1016/S0003-4975(02)03921-8
Miyake, T. et al. Inhibitory effects of NF kappa B decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J. Mol. Cell. Cardiol. 41, 431–440 (2006).
doi: 10.1016/j.yjmcc.2006.04.006
Wang, Y. J., Wang, J. T., Fan, Q. X. & Geng, J. G. Andrographolide inhibits NF-kappa B activation and attenuates neointimal hyperplasia in arterial restenosis. Cell Res. 17, 933–941 (2007).
doi: 10.1038/cr.2007.89
Fledderus, J. O. et al. KLF2 primes the antioxidant transcription factor Nrf2 for activation in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28(7), 1339–1346 (2008).
doi: 10.1161/ATVBAHA.108.165811
Nam, D. et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 297, H1535–H1543 (2009).
doi: 10.1152/ajpheart.00510.2009
White, S. J. et al. Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress. J. Cell. Physiol. 226, 2841–2848 (2011).
doi: 10.1002/jcp.22629

Auteurs

Alexander O Ward (AO)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK.

Gianni D Angelini (GD)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK.

Massimo Caputo (M)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK.

Paul C Evans (PC)

Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield, Sheffield, S10 2TN, UK.

Jason L Johnson (JL)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK.

M Saadeh Suleiman (MS)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK.

Robert M Tulloh (RM)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK.

Sarah J George (SJ)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK.

Mustafa Zakkar (M)

Bristol Medical School, University of Bristol, Research Floor Level 7, Queens' Building, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK. mz207@le.ac.uk.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH